> a longevity researcher Probably Peter Attia? There's also some free to read re... | Hacker News

Hacker Newsnew | past | comments | ask | show | jobs | submit

		sndean on Aug 31, 2022 \| parent \| context \| favorite \| on: Rapamycin, drug used in cancer therapy, emerges as... > a longevity researcher Probably Peter Attia? There's also some free to read review articles (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814615/). No idea about the quality of the journal Aging or the field in general, though.

mod on Aug 31, 2022 [–]

No, Matt Kaeberlein-- here's the transcript of the episode.

https://tim.blog/2022/07/30/matt-kaeberlein-life-extension-t...

Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact